Hangzhou Tigermed Consulting Co., Ltd

SZSE:300347 Stock Report

Market Cap: CN¥39.3b

Hangzhou Tigermed Consulting Balance Sheet Health

Financial Health criteria checks 6/6

Hangzhou Tigermed Consulting has a total shareholder equity of CN¥24.5B and total debt of CN¥3.2B, which brings its debt-to-equity ratio to 13.2%. Its total assets and total liabilities are CN¥30.1B and CN¥5.5B respectively. Hangzhou Tigermed Consulting's EBIT is CN¥1.6B making its interest coverage ratio -3.8. It has cash and short-term investments of CN¥7.5B.

Key information

13.2%

Debt to equity ratio

CN¥3.24b

Debt

Interest coverage ratio-3.8x
CashCN¥7.45b
EquityCN¥24.53b
Total liabilitiesCN¥5.54b
Total assetsCN¥30.07b

Recent financial health updates

Recent updates

Hangzhou Tigermed Consulting Co., Ltd's (SZSE:300347) Share Price Could Signal Some Risk

Aug 21
Hangzhou Tigermed Consulting Co., Ltd's (SZSE:300347) Share Price Could Signal Some Risk

Hangzhou Tigermed Consulting (SZSE:300347) Is Increasing Its Dividend To CN¥0.568

Jul 12
Hangzhou Tigermed Consulting (SZSE:300347) Is Increasing Its Dividend To CN¥0.568

Is Hangzhou Tigermed Consulting (SZSE:300347) A Risky Investment?

Jun 26
Is Hangzhou Tigermed Consulting (SZSE:300347) A Risky Investment?

An Intrinsic Calculation For Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Suggests It's 35% Undervalued

Jun 07
An Intrinsic Calculation For Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Suggests It's 35% Undervalued

Hangzhou Tigermed Consulting Co., Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Apr 28
Hangzhou Tigermed Consulting Co., Ltd Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Apr 08
Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Hangzhou Tigermed Consulting's (SZSE:300347) Profits Appear To Have Quality Issues

Apr 04
Hangzhou Tigermed Consulting's (SZSE:300347) Profits Appear To Have Quality Issues

Hangzhou Tigermed Consulting Co., Ltd Just Missed Earnings - But Analysts Have Updated Their Models

Apr 01
Hangzhou Tigermed Consulting Co., Ltd Just Missed Earnings - But Analysts Have Updated Their Models

Financial Position Analysis

Short Term Liabilities: 300347's short term assets (CN¥11.7B) exceed its short term liabilities (CN¥4.5B).

Long Term Liabilities: 300347's short term assets (CN¥11.7B) exceed its long term liabilities (CN¥1.1B).


Debt to Equity History and Analysis

Debt Level: 300347 has more cash than its total debt.

Reducing Debt: 300347's debt to equity ratio has reduced from 21.5% to 13.2% over the past 5 years.

Debt Coverage: 300347's debt is well covered by operating cash flow (39.1%).

Interest Coverage: 300347 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies